Pharmaceutical The Asia-Pacific solid tumors treatment markets - bladder, ovarian, pancreatic and prostate cancers - is expected to increase from a value of $1 billion in 2012 to $2.3 billion in 2019, at a compound annual growth rate (CAGR) of 12.3%, according to a new report added to the offering of researchandmarkets.com, titled Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies. 8 October 2013